Journal article
Sting-Challenge Demonstrated Tolerance in Patients Undergoing Reduced-dose Jumper Ant Venom Specific Immunotherapy: Validating New Centre Approach in Adult and Children.
Kymble Spriggs, Elizabeth Leahy, Nicole Weibel, Emily Heke, Sara Barnes
The Journal of Allergy and Clinical Immunology: In Practice | Elsevier | Published : 2023
Abstract
Jack Jumper ant venom-specific immunotherapy at a reduced dose of 50 μg/mo maintains clinical effectiveness, obviating severe reactions at sting challenge in both adult and pediatric patients. This updated process is well tolerated in a specialist setting, and can clearly be recommended in this broader population.